Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Transl Res. 2019 Aug 12;215:75–85. doi: 10.1016/j.trsl.2019.08.003

Table 1:

Intracellular targets in the post-translational modifications associated with endogenous negative inhibition of NLRP3 inflammasome priming or activation phases.

Post-translational Modification Target Phase of NLRP3 Inflammasome affected References
(IKK)α Priming via phosphorylation 87
PKA Activation via phosphorylation 9193
PTPN22 Activation via dephosphorylation 96
TRIM31 Activation via ubiquitination 88
ARIH2 Activation via ubiquitination 89
MARCH17 Activation via ubiquitination 95